Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.8 / 5 stars · 42/120 Roast Me

GILEAD SCIENCES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

GILEAD SCIENCES, INC. (GILD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.00 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06

  • GILEAD SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 15.00M shares, a 114.29% increase year-over-year.
  • GILEAD SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.00M shares, a 0.00% change year-over-year.
  • GILEAD SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 3.00M shares, a 57.14% decline year-over-year.
  • GILEAD SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 7.00M shares, a 68.18% decline year-over-year.
  • GILEAD SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.00M shares, a 60.00% decline from fiscal 2024.
  • GILEAD SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.00M shares, a 25.00% increase from fiscal 2023.
  • GILEAD SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.00M shares, a 66.67% decline from fiscal 2022.
  • GILEAD SCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 12.00M shares, a 20.00% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-3015.00M shares
10-Q · filed 2026-08-06
14.00M shares
10-Q · filed 2026-08-06
2026-03-312.00M shares
10-Q · filed 2026-05-07
2025-12-312.00M shares
10-K · filed 2026-02-24
2025-09-303.00M shares
10-Q · filed 2025-11-07
5.00M shares
10-Q · filed 2025-11-07
2025-06-307.00M shares
10-Q · filed 2026-08-06
5.00M shares
10-Q · filed 2026-08-06
2025-03-312.00M shares
10-Q · filed 2026-05-07
2024-12-315.00M shares
10-K · filed 2026-02-24
2024-09-307.00M shares
10-Q · filed 2025-11-07
14.00M shares
10-Q · filed 2025-11-07
2024-06-3022.00M shares
10-Q · filed 2025-08-07
19.00M shares
10-Q · filed 2025-08-07
2024-03-3113.00M shares
10-Q · filed 2025-05-07
2023-12-314.00M shares
10-K · filed 2026-02-24
2023-09-306.00M shares
10-Q · filed 2024-11-12
4.00M shares
10-Q · filed 2024-11-12
2023-06-305.00M shares
10-Q · filed 2024-08-08
3.00M shares
10-Q · filed 2024-08-08
2023-03-313.00M shares
10-Q · filed 2024-05-08
2022-12-3112.00M shares
10-K · filed 2025-02-28
2022-09-3017.00M shares
10-Q · filed 2023-11-07
17.00M shares
10-Q · filed 2023-11-07
2022-06-3020.00M shares
10-Q · filed 2023-08-04
17.00M shares
10-Q · filed 2023-08-04
2022-03-3116.00M shares
10-Q · filed 2023-05-03
2021-12-3115.00M shares
10-K · filed 2024-02-23
2021-09-3014.00M shares
10-Q · filed 2022-11-02
15.00M shares
10-Q · filed 2022-11-02
2021-06-3019.00M shares
10-Q · filed 2022-08-08
16.00M shares
10-Q · filed 2022-08-08
2021-03-3115.00M shares
10-Q · filed 2022-05-04
2020-12-3113.00M shares
10-K · filed 2023-02-22
2020-09-3013.00M shares
10-Q · filed 2021-11-03
38.00M shares
10-Q · filed 2021-11-03
2020-06-3038.00M shares
10-Q · filed 2021-08-05
37.00M shares
10-Q · filed 2021-08-05
2020-03-3114.00M shares
10-Q · filed 2021-05-06
2019-12-3114.00M shares
10-K · filed 2022-02-23
2019-09-3040.00M shares
10-Q · filed 2020-11-04
14.00M shares
10-Q · filed 2020-11-04
2019-06-3017.00M shares
10-Q · filed 2020-08-06
14.00M shares
10-Q · filed 2020-08-06
2019-03-3116.00M shares
10-Q · filed 2020-05-06
2018-12-3113.00M shares
10-K · filed 2021-02-25
2018-09-3012.00M shares
10-Q · filed 2019-11-05
13.00M shares
10-Q · filed 2019-11-05
2018-06-3021.00M shares
10-Q · filed 2019-08-06
16.00M shares
10-Q · filed 2019-08-06
2018-03-3112.00M shares
10-Q · filed 2019-05-08
2017-12-3111.00M shares
10-K · filed 2020-02-25
2017-09-309.00M shares
10-Q · filed 2018-11-06
9.00M shares
10-Q · filed 2018-11-06
2017-06-3013.00M shares
10-Q · filed 2018-08-06
10.00M shares
10-Q · filed 2018-08-06
2017-03-319.00M shares
10-Q · filed 2018-05-09
2016-12-313.00M shares
10-K · filed 2019-02-26
2016-09-304.00M shares
10-Q · filed 2017-11-07
4.00M shares
10-Q · filed 2017-11-07
2016-03-314.00M shares
10-Q · filed 2017-05-10
2015-12-311.00M shares
10-K · filed 2018-02-27
2015-09-301.00M shares
10-Q · filed 2015-11-04
1.00M shares
10-Q · filed 2015-11-04
2015-06-301.00M shares
10-Q · filed 2015-08-05
1.00M shares
10-Q · filed 2015-08-05
2015-03-311.00M shares
10-Q · filed 2016-05-06
2014-12-311.00M shares
10-K · filed 2017-02-27
2014-09-301.00M shares
10-Q · filed 2015-11-04
1.10M shares
10-Q · filed 2014-11-05
1.00M shares
10-Q · filed 2015-11-04
2014-06-301.00M shares
10-Q · filed 2015-08-05
1.10M shares
10-Q · filed 2014-08-04
1.00M shares
10-Q · filed 2015-08-05
900.00K shares
10-Q · filed 2014-08-04
2014-03-311.00M shares
10-Q · filed 2015-05-08
700.00K shares
10-Q · filed 2014-05-07
2013-12-310.00 shares
10-K · filed 2016-02-24
100.00K shares
10-K · filed 2014-02-25
2013-09-30100.00K shares
10-Q · filed 2014-11-05
900.00K shares
10-Q · filed 2014-11-05
2013-06-301.00M shares
10-Q · filed 2014-08-04
1.70M shares
10-Q · filed 2014-08-04
2013-03-311.30M shares
10-Q · filed 2014-05-07
2012-12-315.00M shares
10-K · filed 2015-02-25
5.10M shares
10-K · filed 2013-02-27
2012-09-304.20M shares
10-Q · filed 2013-10-31
2.10M shares
10-Q · filed 2012-11-06
11.50M shares
10-Q · filed 2013-10-31
5.70M shares
10-Q · filed 2012-11-06
2012-06-309.20M shares
10-Q · filed 2013-08-01
9.20M shares
10-Q · filed 2013-08-01
2012-03-3121.80M shares
10-Q · filed 2013-05-08
10.90M shares
10-Q · filed 2012-05-04
2011-12-3142.20M shares
10-K · filed 2014-02-25
21.10M shares
10-K · filed 2012-02-23
2011-09-3021.00M shares
10-Q · filed 2012-11-06
21.40M shares
10-Q · filed 2012-11-06
2011-06-3021.60M shares
10-Q · filed 2012-08-01
21.80M shares
10-Q · filed 2012-08-01
2011-03-3122.10M shares
10-Q · filed 2012-05-04
2010-12-3145.00M shares
10-K · filed 2013-02-27
22.50M shares
10-K · filed 2011-02-28
2010-09-3027.10M shares
10-Q · filed 2011-11-04
22.60M shares
10-Q · filed 2011-11-04
2010-06-3023.40M shares
10-Q · filed 2011-08-05
19.50M shares
10-Q · filed 2011-08-05
2010-03-3118.00M shares
10-Q · filed 2011-05-09
2009-12-3117.40M shares
10-K · filed 2012-02-23
2009-09-3016.90M shares
10-Q · filed 2010-11-08
17.10M shares
10-Q · filed 2010-11-08
2009-06-3018.60M shares
10-Q · filed 2010-08-09
16.70M shares
10-Q · filed 2010-08-09
2008-12-3111.40M shares
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31